Prestige Biopharma Successfully Concludes 'Prestige Symposium' on Aging
Prestige Biopharma IDC, the drug research and development subsidiary of Prestige Biopharma, announced on the 8th that it had successfully concluded the '2026 Prestige Symposium'.
Attendees are taking a commemorative photo at the '2026 Prestige Symposium' held on the 4th / Photo by Prestige Biopharma
View original imageThe symposium, which was held on the 4th, focused on the theme of 'Mechanisms of Aging and Recent Trends in Aging-Related Diseases'. The event aimed to provide a comprehensive overview that connected fundamental research into the mechanisms of aging with therapeutic development strategies, serving as a venue to share the latest research findings and treatment strategies.
In the keynote speech, Dr. Arthur Levine introduced the advances and potential of oligonucleotide therapeutics and presented new approaches that could be applied in the treatment of aging-related diseases. Subsequent sessions featured presentations by Professor Jung Hae-Young of Pusan National University, Professor Lee Seung-Jae of KAIST, Professor Yoon Jin-Ho of Dong-A University, Lee Ho-Young, senior researcher at Syntekabio, Professor Kang Chan-Hee of Seoul National University, Professor Ryu Dong-Ryeol of Gwangju Institute of Science and Technology, Professor Lee Jae-Won of Pusan National University, and Kwon Ki-Seon, CEO of Aventi. They shared their research results related to aging and discussed strategies for research and drug development.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Ko Sang-Seok, CEO of Prestige Biopharma IDC, stated, "This symposium was significant in that it brought together a wide range of research achievements connecting the fundamental mechanisms of aging with the actual development of new drugs, and allowed us to discuss new therapeutic possibilities." He added, "We will continue to expand exchanges with domestic and international researchers and industry in order to strengthen the collaborative foundation so that research achievements in aging-related diseases can lead to innovative drug development."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.